Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


06.05.2019

1 Am J Clin Oncol
1 Am J Pathol
1 Ann Surg Oncol
2 BMC Cancer
1 Breast Cancer (Dove Med Press)
3 Breast Cancer Res
8 Breast Cancer Res Treat
1 Cancer
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
2 Cancer Res
1 Clin Breast Cancer
2 Clin Cancer Res
1 Exp Cell Res
1 Int J Radiat Oncol Biol Phys
3 J Biol Chem
2 J Clin Oncol
1 J Natl Cancer Inst
6 Lancet Oncol
6 Oncogene
1 PLoS Comput Biol
1 PLoS Genet
3 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. YU JB, Pollack CE, Herrin J, Zhu W, et al
    Persistent Use of Extended Fractionation Palliative Radiotherapy for Medicare Beneficiaries With Metastatic Breast Cancer, 2011 to 2014.
    Am J Clin Oncol. 2019 Apr 24. doi: 10.1097/COC.0000000000000548.
    PubMed     Text format     Abstract available


    Am J Pathol

  2. COLEMAN WB
    Breast Ductal Carcinoma in Situ: Precursor to Invasive Breast Cancer.
    Am J Pathol. 2019;189:942-945.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  3. HENNIGS A, Riedel F, Feisst M, Kopke M, et al
    Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study.
    Ann Surg Oncol. 2019 May 2. pii: 10.1245/s10434-019-07388.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. MEERSON A, Eliraz Y, Yehuda H, Knight B, et al
    Obesity impacts the regulation of miR-10b and its targets in primary breast tumors.
    BMC Cancer. 2019;19:86.
    PubMed     Text format     Abstract available

  5. KANOMATA N, Kurebayashi J, Koike Y, Yamaguchi R, et al
    CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature.
    BMC Cancer. 2019;19:76.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  6. MOMENIMOVAHED Z, Salehiniya H
    Epidemiological characteristics of and risk factors for breast cancer in the world.
    Breast Cancer (Dove Med Press). 2019;11:151-164.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  7. DOHERTY MR, Parvani JG, Tamagno I, Junk DJ, et al
    The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
    Breast Cancer Res. 2019;21:54.
    PubMed     Text format     Abstract available

  8. WEBER-LASSALLE N, Borde J, Weber-Lassalle K, Horvath J, et al
    Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Breast Cancer Res. 2019;21:55.
    PubMed     Text format     Abstract available

  9. DEMICHELI R, Dillekas H, Straume O, Biganzoli E, et al
    Distant metastasis dynamics following subsequent surgeries after primary breast cancer removal.
    Breast Cancer Res. 2019;21:57.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  10. TEYSIR J, Gegechkori N, Wisnivesky JP, Lin JJ, et al
    Racial disparities in surveillance mammography among older breast cancer survivors.
    Breast Cancer Res Treat. 2019 Apr 26. pii: 10.1007/s10549-019-05250.
    PubMed     Text format     Abstract available

  11. WAGONER CW, Choi SK, Deal AM, Lee JT, et al
    Establishing physical activity in breast cancer: self-report versus activity tracker.
    Breast Cancer Res Treat. 2019 Apr 30. pii: 10.1007/s10549-019-05263.
    PubMed     Text format     Abstract available

  12. BAKER HA, Fabian CJ, Hastings RC, Dixon DA, et al
    Circulating adipose stromal cells as a response biomarker in phase II energy balance trials of obese breast cancer survivors and high-risk women.
    Breast Cancer Res Treat. 2019 Apr 30. pii: 10.1007/s10549-019-05251.
    PubMed     Text format     Abstract available

  13. ELFGEN C, Montagna G, Schmid SM, Bierbauer W, et al
    Noncompliance with palliative systemic therapy in patients with distant metastatic breast cancer: a blind spot for oncologists?
    Breast Cancer Res Treat. 2019 May 2. pii: 10.1007/s10549-019-05255.
    PubMed     Text format     Abstract available

  14. ACKLAND SP, Gebski V, Zdenkowski N, Wilson A, et al
    Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311.
    Breast Cancer Res Treat. 2019 Apr 26. pii: 10.1007/s10549-019-05187.
    PubMed     Text format     Abstract available

  15. SESTAK I, Martin M, Dubsky P, Kronenwett R, et al
    Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
    Breast Cancer Res Treat. 2019 Apr 30. pii: 10.1007/s10549-019-05226.
    PubMed     Text format     Abstract available

  16. ROTTER J, Wilson L, Greiner MA, Pollack CE, et al
    Shared-patient physician networks and their impact on the uptake of genomic testing in breast cancer.
    Breast Cancer Res Treat. 2019 Apr 26. pii: 10.1007/s10549-019-05248.
    PubMed     Text format     Abstract available

  17. KIM JY, Lee DW, Lee KH, Min A, et al
    Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients.
    Breast Cancer Res Treat. 2019 Apr 26. pii: 10.1007/s10549-019-05249.
    PubMed     Text format     Abstract available


    Cancer

  18. DEMISSEI BG, Finkelman BS, Hubbard RA, Zhang L, et al
    Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy.
    Cancer. 2019 May 1. doi: 10.1002/cncr.32149.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  19. JUNG SY, Jung KW, Ha J, Won YJ, et al
    Different Patterns of Conditional Survival of Breast Cancer Patients by Age and Histologic types: Evidence from the Korean Nationwide Registry.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 26. pii: 1055-9965.EPI-18-1072.
    PubMed     Text format     Abstract available


    Cancer Lett

  20. DONG Q, Yang B, Han JG, Zhang MM, et al
    A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways.
    Cancer Lett. 2019 Apr 28. pii: S0304-3835(19)30268.
    PubMed     Text format     Abstract available

  21. WANG H, Yao F, Luo S, Ma K, et al
    A mutual activation loop between the Ca(2+)-activated chloride channel TMEM16A and EGFR/STAT3 signaling promotes breast cancer tumorigenesis.
    Cancer Lett. 2019 Apr 28. pii: S0304-3835(19)30264.
    PubMed     Text format     Abstract available


    Cancer Res

  22. STEWART RL, Updike KL, Factor RE, Henry NL, et al
    A multigene assay determines risk of recurrence in patients with triple-negative breast cancer.
    Cancer Res. 2019 May 2. pii: 0008-5472.CAN-18-3014.
    PubMed     Text format     Abstract available

  23. VALETA-MAGARA A, Gadi A, Volta V, Walters B, et al
    Inflammatory Breast Cancer Promotes Development of M2 Tumor-associated Macrophages and Cancer Mesenchymal Cells Through a Complex Cytokine Network.
    Cancer Res. 2019 May 1. pii: 0008-5472.CAN-17-2158.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  24. TIAINEN L, Hamalainen M, Luukkaala T, Tanner M, et al
    Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Apr 4. pii: S1526-8209(18)30840.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  25. MEIJER TG, Verkaik NS, Sieuwerts AM, van Riet J, et al
    Correction: Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects.
    Clin Cancer Res. 2019;25:2935.
    PubMed     Text format    

  26. MITTENDORF EA, Lu B, Melisko M, Price Hiller J, et al
    Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial.
    Clin Cancer Res. 2019 Apr 29. pii: 1078-0432.CCR-18-2867.
    PubMed     Text format     Abstract available


    Exp Cell Res

  27. ZHOU R, Wang S, Wen H, Wang M, et al
    The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models.
    Exp Cell Res. 2019 Apr 26. pii: S0014-4827(19)30209.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  28. DECESARIS C, Rice SR, Bentzen SM, Jatczak J, et al
    Quantification of Acute Skin Toxicities in Breast Cancer Patients Undergoing Adjuvant Proton vs. Photon Radiation Therapy: A single institutional experience.
    Int J Radiat Oncol Biol Phys. 2019 Apr 24. pii: S0360-3016(19)30647.
    PubMed     Text format     Abstract available


    J Biol Chem

  29. CUESTA R, Berman AY, Alayev A, Holz MK, et al
    Estrogen receptor alpha promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
    J Biol Chem. 2019;294:2267-2278.
    PubMed     Text format     Abstract available

  30. TUROWEC JP, Lau EWT, Wang X, Brown KR, et al
    Functional genomic characterization of a synthetic anti-HER3 antibody reveals a role for ubiquitination by RNF41 in the anti-proliferative response.
    J Biol Chem. 2019;294:1396-1409.
    PubMed     Text format     Abstract available

  31. REIS LMD, Adamoski D, Oliveira Souza RO, Rodrigues Ascencao CF, et al
    Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
    J Biol Chem. 2019 Apr 30. pii: RA119.008180. doi: 10.1074/jbc.RA119.008180.
    PubMed     Text format     Abstract available


    J Clin Oncol

  32. YU KD, Shao ZM
    Comparison of Time-Dependent Contralateral Breast Cancer Incidence Requires Comparable Lengths of Follow-Up.
    J Clin Oncol. 2019 Apr 29:JCO1802468. doi: 10.1200/JCO.18.02468.
    PubMed     Text format    

  33. KUEMMEL S, Holtschmidt J, Gerber B, Von der Assen A, et al
    Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.
    J Clin Oncol. 2019 May 1:JCO1802092. doi: 10.1200/JCO.18.02092.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  34. PRAT A, Pascual T, De Angelis C, Gutierrez C, et al
    HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade.
    J Natl Cancer Inst. 2019 Apr 30. pii: 5475264. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Oncol

  35. GNANT M, Pfeiler G, Frantal S
    Denosumab in early-stage breast cancer - Authors' reply.
    Lancet Oncol. 2019;20:236.
    PubMed     Text format    

  36. WANDER SA, Spring LM, Bardia A
    Genetics to epigenetics: targeting histone deacetylases in hormone receptor-positive metastatic breast cancer.
    Lancet Oncol. 2019 Apr 26. pii: S1470-2045(19)30279.
    PubMed     Text format    

  37. TAMURA K, Tsurutani J, Takahashi S, Iwata H, et al
    Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.
    Lancet Oncol. 2019 Apr 29. pii: S1470-2045(19)30097.
    PubMed     Text format     Abstract available

  38. RODRIGUEZ EG, Aubry-Rozier B, Stoll D, Lamy O, et al
    Denosumab in early-stage breast cancer.
    Lancet Oncol. 2019;20:e233.
    PubMed     Text format    

  39. BRANDAO M, Debiasi M, de Azambuja E
    Denosumab in early-stage breast cancer.
    Lancet Oncol. 2019;20:e234-e235.
    PubMed     Text format    

  40. JIANG Z, Li W, Hu X, Zhang Q, et al
    Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet Oncol. 2019 Apr 26. pii: S1470-2045(19)30164.
    PubMed     Text format     Abstract available


    Oncogene

  41. YOSHINO Y, Qi H, Kanazawa R, Sugamata M, et al
    RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells.
    Oncogene. 2019;38:3077-3092.
    PubMed     Text format     Abstract available

  42. GOMES AM, Carron EC, Mills KL, Dow AM, et al
    Stromal Gas6 promotes the progression of premalignant mammary cells.
    Oncogene. 2019;38:2437-2450.
    PubMed     Text format     Abstract available

  43. GOODING AJ, Zhang B, Gunawardane L, Beard A, et al
    The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.
    Oncogene. 2019;38:2020-2041.
    PubMed     Text format     Abstract available

  44. MARQUES M, Jangal M, Wang LC, Kazanets A, et al
    Oncogenic activity of poly (ADP-ribose) glycohydrolase.
    Oncogene. 2019;38:2177-2191.
    PubMed     Text format     Abstract available

  45. FEDOROVA O, Petukhov A, Daks A, Shuvalov O, et al
    Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.
    Oncogene. 2019;38:2108-2122.
    PubMed     Text format     Abstract available

  46. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
    S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0599.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  47. DE ALMEIDA BP, Vieira AF, Paredes J, Bettencourt-Dias M, et al
    Pan-cancer association of a centrosome amplification gene expression signature with genomic alterations and clinical outcome.
    PLoS Comput Biol. 2019;15:e1006832.
    PubMed     Text format     Abstract available


    PLoS Genet

  48. DING L, Shunkwiler LB, Harper NW, Zhao Y, et al
    Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
    PLoS Genet. 2019;15:e1008002.
    PubMed     Text format     Abstract available


    PLoS One

  49. ADLER G, Kaufman G, Simon-Tuval T
    Healthcare utilization of breast cancer patients following telephone-based consultations of oncology nurse navigator via telemedical care.
    PLoS One. 2019;14:e0216365.
    PubMed     Text format     Abstract available

  50. TVEITARAS MK, Selheim F, Sortland K, Reed RK, et al
    Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model.
    PLoS One. 2019;14:e0215909.
    PubMed     Text format     Abstract available

  51. LEI K, He X, Yu L, Ni C, et al
    Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    PLoS One. 2019;14:e0215948.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  52. ONDECK MG, Kumar A, Placone JK, Plunkett CM, et al
    Dynamically stiffened matrix promotes malignant transformation of mammary epithelial cells via collective mechanical signaling.
    Proc Natl Acad Sci U S A. 2019;116:3502-3507.
    PubMed     Text format     Abstract available


    Radiology

  53. CHOI SH, Choi JS, Han BK, Ko EY, et al
    Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Radiology. 2019 Apr 30:181844. doi: 10.1148/radiol.2019181844.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: